#438: A Conversation About Quality: A Global Regulators Discussion
Monday, June 15, 2026 2:30 PM to 3:30 PM · 1 hr. (America/New_York)
201AB
08: RegPolicy-Strategy-GlobalCollaboration09: RD-Quality-Compliance
Information
This forum will present the perspectives of global regulatory agencies on encouraging a high standard for quality in pharmaceutical products. The panel will discuss their vision, key initiatives, challenges on how to improve drug quality worldwide.
CE
ACPECMERN
Session Level
Intermediate
Learning Objectives
Describe regulatory agencies’ shared priorities about drug quality in support of a secure, resilient, and high-quality pharmaceutical supply chain; Identify the role of oversight to ensure high-quality pharmaceutical manufacturing; Explain how regulators can work in partnership to reach a coherent, predictable, and efficient global regulatory environment for the benefit of global public health.
Speakers
Mark Abdoo
Associate Commissioner for Global Policy and StrategyFDA
Lawrence Tallon
Chief Executive OfficerMedicines and Healthcare products Regulatory Agency (MHRA)
Delese Mimi Darko
Director GeneralAfrican Medicines Agency (AMA)
Grace Graham
Deputy Commissioner for Policy, Legislation, and International AffairsFDA
Emer Cooke
Executive DirectorEuropean Medicines Agency